20 min listen
Immune Checkpoint Inhibitors in Urothelial Bladder Carcinoma with Dr Joaquim Bellmunt
Immune Checkpoint Inhibitors in Urothelial Bladder Carcinoma with Dr Joaquim Bellmunt
ratings:
Length:
42 minutes
Released:
Dec 15, 2020
Format:
Podcast episode
Description
Dr Joaquim Bellmunt from the Beth Israel Deaconess Medical Center in Boston discusses the use of immune checkpoint inhibitors in urothelial bladder carcinoma.
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayCheckpointInhibitionUBC20).
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayCheckpointInhibitionUBC20).
Released:
Dec 15, 2020
Format:
Podcast episode
Titles in the series (100)
Dr Benjamin Levy on the Management of Lung Cancer in the COVID-19 Era: Dr Benjamin Levy from Johns Hopkins comments on changes to the surgical and targeted treatment of lung cancer during COVID-19 and challenges in the management of immune-related adverse events with immune checkpoint inhibitors. by Oncology Today with Dr Neil Love